AUTL — AUTOLUS THERAPEUTICS PLC

Ownership history in Squarepoint Ops LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in AUTOLUS THERAPEUTICS PLC (AUTL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2020 Q2)
Avg. % of fund
0.0%
First filed
2020 Q1
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 91,957 +78,450 +580.8% 0.00% $150K $1.63
2025 Q2 REDUCED 13,507 -7,082 -34.4% 0.00% $31K $2.28
2024 Q2 ADDED 20,589 +10,182 +97.8% 0.00% $72K $3.48
2022 Q4 REDUCED 10,407 -72,195 -87.4% 0.00% $20K $1.90
2021 Q1 ADDED 82,602 +52,584 +175.2% 0.00% $473K $5.73
2020 Q2 ADDED 30,018 +14,722 +96.2% 0.01% $481K $16.03
2020 Q1 INITIATED 15,296 — — 0.00% $92K $5.99
% of Fund (quarterly)    AUTL price (monthly, adj. close)

Other funds also holding AUTL

As of 2025 Q4 — sorted by position size

Syncona Portfolio Ltd 3Y 96.48% MAK CAPITAL ONE LLC 3Y 7Y 6.57% Tetragon Partners GP Ltd 3Y 7Y 3.99% Atle Fund Management AB 3Y 7Y 0.74% ARMISTICE CAPITAL, LLC 3Y 7Y 0.41% Frazier Life Sciences Management, L.P. 3Y 0.25% Laurion Capital Management LP 3Y 7Y 0.2% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.19% EDENTREE ASSET MANAGEMENT Ltd 0.18% Aubrey Capital Management Ltd 3Y 7Y 0.18%
← Back to Squarepoint Ops LLC Holdings